COOK WILLIAM M
COOK WILLIAM M's purchase track record
How the stock did after each of COOK WILLIAM M's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/29/2025 | MATV | $29K | +113.9% | +120.3% | +15.8% |
| 11/15/2024 | MATV | $31K | -23.4% | -47.9% | +1.5% |
| 9/15/2023 | MATV | $23K | -9.3% | +17.3% | +15.0% |
| 9/12/2023 | AXTA | $40K | +22.4% | +25.0% | +16.0% |
| 3/14/2023 | AXTA | $74K | +9.1% | -8.6% | +13.8% |
| 11/14/2022 | MATV | $44K | +41.6% | -8.2% | +4.5% |
| 9/19/2022 | MATV | $37K | -22.6% | -13.3% | +1.3% |
| 3/4/2022 | AXTA | $49K | +10.5% | +1.0% | -9.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Mativ Holdings included in Zacks.com highlights. Mativ Holdings was listed among the companies highlighted by Zacks.com in a recent feature that also covered Kohl's, Lifetime Brands, Ultrapar and Chatham Lodging. The inclusion brings attention to the stock as analysts discuss its performance. The mention comes as the shares trade near a long‑term support level of $7.71.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
IDEX price target raised to $285 by RBC Capital. RBC Capital has kept its outperform rating on IDEX and lifted the target price to $285, reflecting confidence in the company's earnings outlook. The move comes as the stock trades near the upper end of its 52‑week range and shows a moderately strong RSI of 63.3. Analysts see the firm’s valuation as still attractive compared to peers. The update may influence how investors view IDEX’s growth prospects.
Transaction History
| AXTA | ▲ Buy | Option Exercise | 5,832 | — | 3/4/2026 | View on chart |
| MATV | ▲ Buy | Open Market | 5,000 | $29K | 5/29/2025 | View on chart |
| AXTA | ▲ Buy | Option Exercise | 6,157 | — | 2/28/2025 | View on chart |
| MATV | ▲ Buy | Open Market | 2,500 | $31K | 11/15/2024 | View on chart |
| AXTA | ▲ Buy | Option Exercise | 6,711 | — | 2/28/2024 | View on chart |
| MATV | ▲ Buy | Open Market | 1,500 | $23K | 9/15/2023 | View on chart |
| AXTA | ▲ Buy | Open Market | 1,500 | $40K | 9/12/2023 | View on chart |
| AXTA | ▲ Buy | Open Market | 2,500 | $74K | 3/14/2023 | View on chart |
| AXTA | ▲ Buy | Option Exercise | 6,939 | — | 2/15/2023 | View on chart |
| MATV | ▲ Buy | Open Market | 1,500 | $44K | 11/14/2022 | View on chart |
| MATV | ▲ Buy | Grant | 1,189 | $26K | 10/3/2022 | View on chart |
| MATV | ▲ Buy | Open Market | 1,500 | $37K | 9/19/2022 | View on chart |
| IEX | ▲ Buy | Grant | 1,095 | $0 | 5/6/2022 | View on chart |
| AXTA | ▲ Buy | Open Market | 2,000 | $49K | 3/4/2022 | View on chart |
| AXTA | ▲ Buy | Option Exercise | 7,208 | — | 3/3/2022 | View on chart |
| IEX | ▲ Buy | Option Exercise | 3,530 | $151K | 11/1/2021 | View on chart |
| IEX | ▼ Sell | Open Market | 679 | $151K | 11/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
UBS Cuts Axalta Price Target to $36, Maintains Neutral Rating
UBS lowered its price target for Axalta to $36 while keeping a neutral stance. The company also announced the date for its third-quarter 2026 earnings call. These updates provide new context as Axalta trades near its 52-week low, with the stock currently sitting above a key support level.
UBS Cuts Axalta Price Target to $36, Maintains Neutral Rating. UBS lowered its price target for Axalta to $36 while keeping a neutral stance. The company also announced the date for its third-quarter 2026 earnings call. These updates provide new context as Axalta trades near its 52-week low, with the stock currently sitting above a key support level.